{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:49:57Z","timestamp":1791978597492,"version":"4.4.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pharmthera.2020.107647","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T20:18:55Z","timestamp":1596485935000},"page":"107647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination"],"prefix":"10.1016","volume":"217","author":[{"given":"Jinghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhou","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107647_bb0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molcel.2016.05.009","article-title":"MINDY-1 Is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes","volume":"63","author":"Abdul Rehman","year":"2016","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1124\/mol.109.056564","article-title":"Toward a systems level understanding of organic anion and other multispecific drug transporters: A remote sensing and signaling hypothesis","volume":"76","author":"Ahn","year":"2009","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186924","article-title":"Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner","volume":"12","author":"Alam","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbamcr.2004.10.003","article-title":"Mechanism and function of deubiquitinating enzymes","volume":"1695","author":"Amerik","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.CRJ06006X","article-title":"Organic anion transporter family: current knowledge","volume":"100","author":"Anzai","year":"2006","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0030","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1074\/jbc.RA118.002233","article-title":"Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion","volume":"293","author":"Appikonda","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/164_2017_53","article-title":"Regulation of cardiac voltage-gated sodium channel by kinases: Roles of protein kinases A and C","volume":"246","author":"Aromolaran","year":"2018","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1081\/DMR-100101947","article-title":"Oxidant mechanisms in toxic acute renal failure","volume":"31","author":"Baliga","year":"1999","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0050","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0055","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1073\/pnas.0606702104","article-title":"SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5","volume":"104","author":"Benson","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0060","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ckj\/sfw010","article-title":"Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling","volume":"9","author":"Bhatnagar","year":"2016","journal-title":"Clinical Kidney Journal"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000363251","article-title":"Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury","volume":"40","author":"Bischoff","year":"2014","journal-title":"American Journal of Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/phy2.243","article-title":"PAH clearance after renal ischemia and reperfusion is a function of impaired expression of basolateral Oat1 and Oat3","volume":"2","author":"Bischoff","year":"2014","journal-title":"Physiological Reports"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbadis.2006.05.011","article-title":"Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3","volume":"1762","author":"Brandoni","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0080","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/ajmg.a.61553","article-title":"Oligosaccharyltransferase complex-congenital disorders of glycosylation: A novel congenital disorder of glycosylation","volume":"182A","author":"Bryant","year":"2020","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0090","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M117.796516","article-title":"The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis","volume":"292","author":"Bush","year":"2017","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0095","doi-asserted-by":"crossref","first-page":"37885","DOI":"10.1074\/jbc.M707989200","article-title":"The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel","volume":"282","author":"Butterworth","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s13238-017-0486-3","article-title":"The role of ubiquitination and deubiquitination in the regulation of cell junctions","volume":"9","author":"Cai","year":"2018","journal-title":"Protein & Cell"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/bies.20210","article-title":"Regulatory cross-talk between lysine acetylation and ubiquitination: Role in the control of protein stability","volume":"27","author":"Caron","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0110","doi-asserted-by":"crossref","first-page":"F293","DOI":"10.1152\/ajprenal.00251.2002","article-title":"Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases","volume":"284","author":"Cetinkaya","year":"2003","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0115","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","article-title":"Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta","volume":"275","author":"Cha","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0120","doi-asserted-by":"crossref","first-page":"F247","DOI":"10.1152\/ajprenal.00139.2008","article-title":"Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis","volume":"295","author":"Chen","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp700114j","article-title":"Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity","volume":"5","author":"Cheng","year":"2008","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0130","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1124\/dmd.114.058529","article-title":"Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3","volume":"42","author":"Chioukh","year":"2014","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009360","article-title":"Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1","volume":"5","author":"Cho","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/pmic.201300387","article-title":"Cell surface protein glycosylation in cancer","volume":"14","author":"Christiansen","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0145","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","article-title":"Deubiquitylases from genes to organism","volume":"93","author":"Clague","year":"2013","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0091270011400414","article-title":"In vitro and in vivo assessment of renal drug transporters in the disposition of mesna and dimesna","volume":"52","author":"Cutler","year":"2012","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.06.013","article-title":"Post-translational modifications of transporters","volume":"192","author":"Czuba","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbamem.2003.08.015","article-title":"The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules","volume":"1618","author":"Dantzler","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0165","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"1864","author":"Deutschmann","year":"2018","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004049","article-title":"The roles of post-translational modifications in the context of protein interaction networks","volume":"11","author":"Duan","year":"2015","journal-title":"PLoS Computational Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.10.048","article-title":"Angiotensin II inhibits activity of human organic anion transporter 3 through activation of protein kinase Calpha: accelerating endocytosis of the transporter","volume":"627","author":"Duan","year":"2010","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0180","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/mol.110.070185","article-title":"Transmembrane peptide as potent inhibitor of oligomerization and function of human organic anion transporter 1","volume":"79","author":"Duan","year":"2011","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0185","first-page":"322","article-title":"Regulation of human organic anion transporter 4 by parathyroid hormone-related protein and protein kinase A","volume":"3","author":"Duan","year":"2012","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2009.08.002","article-title":"Short-term regulation of organic anion transporters","volume":"125","author":"Duan","year":"2010","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0195","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0200","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1016\/j.cub.2019.01.003","article-title":"Protein glycosylation","volume":"29","author":"Eichler","year":"2019","journal-title":"Current Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/pr.111.004614","article-title":"Organic anion transporters and their implications in pharmacotherapy","volume":"64","author":"Emami Riedmaier","year":"2012","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.phrs.2008.09.013","article-title":"Organic anion transporter 3 inhibitors as potential novel antihypertensives","volume":"58","author":"Eraly","year":"2008","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Eraly","year":"2008","journal-title":"Physiological Genomics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0220","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1074\/jbc.M508050200","article-title":"Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice","volume":"281","author":"Eraly","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0225","series-title":"American Association of Pharmaceutical Scientists Annual Meeting, Washington, DC., Abstract No. W1030-05-038","article-title":"Proteasome inhibitors bortezomib and carfilzomib stimulate the transport activity of human organic anion transporter 3 (abstract)","author":"Fan","year":"2018"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107647_bb0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/mol.119.118653","article-title":"Proteasome inhibitors bortezomib and carfilzomib stimulate the transport activity of human organic anion transporter 1","volume":"97","author":"Fan","year":"2020","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0235","author":"FDA"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejps.2015.10.008","article-title":"Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats","volume":"81","author":"Feng","year":"2016","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10545-018-0156-5","article-title":"Recognizable phenotypes in CDG","volume":"41","author":"Ferreira","year":"2018","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0250","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","article-title":"Sumoylation: a regulatory protein modification in health and disease","volume":"82","author":"Flotho","year":"2013","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchemneu.2016.10.004","article-title":"Phosphorylation mechanisms in dopamine transporter regulation","volume":"83-84","author":"Foster","year":"2017","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0260","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.111.187732","article-title":"In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats","volume":"341","author":"Fujita","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0265","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrm3011","article-title":"The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition","volume":"11","author":"Gareau","year":"2010","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cpt196893345","article-title":"Apparent effect of probenecid on the distribution of penicillins in man","volume":"9","author":"Gibaldi","year":"1968","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0280","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1101\/gad.1214604","article-title":"SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?","volume":"18","author":"Gill","year":"2004","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fnmol.2016.00004","article-title":"The ubiquitin-proteasome system: Potential therapeutic targets for Alzheimer\u2019s disease and spinal cord injury","volume":"9","author":"Gong","year":"2016","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/iub.1244","article-title":"Wrestling with stress: Roles of protein SUMOylation and deSUMOylation in cell stress response","volume":"66","author":"Guo","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.taap.2013.04.029","article-title":"JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats","volume":"271","author":"Guo","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0300","first-page":"1081","article-title":"The post-translational modification, SUMOylation, and cancer (Review)","volume":"52","author":"Han","year":"2018","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tox.2010.07.013","article-title":"Post-translational modification by SUMO","volume":"278","author":"Hannoun","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0310","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.bmc.2014.04.003","article-title":"Design, synthesis and molecular docking of amide and urea derivatives as Escherichia coli PDHc-E1 inhibitors","volume":"22","author":"He","year":"2014","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0315","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1128\/MCB.23.8.2953-2968.2003","article-title":"Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1","volume":"23","author":"Hietakangas","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","article-title":"Emerging transporters of clinical importance: an update from the International Transporter Consortium","volume":"94","author":"Hillgren","year":"2013","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0325","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.109.160515","article-title":"Putative transmembrane domain 12 of the human organic anion transporter hOAT1 determines transporter stability and maturation efficiency","volume":"332","author":"Hong","year":"2010","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0330","doi-asserted-by":"crossref","first-page":"32285","DOI":"10.1074\/jbc.M501447200","article-title":"Human organic anion transporter hOAT1 forms homooligomers","volume":"280","author":"Hong","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0335","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1021\/acs.molpharmaceut.6b00332","article-title":"Identification and quantitative assessment of uremic solutes as inhibitors of renal organic anion transporters, OAT1 and OAT3","volume":"13","author":"Hsueh","year":"2016","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0340","first-page":"1","article-title":"Crosstalk between the SUMO and ubiquitin pathways","author":"Hunter","year":"2008","journal-title":"Ernst Schering Foundation Symposium Proceedings"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2017.11.001","article-title":"Renal organic anion transporters in drug-drug interactions and diseases","volume":"112","author":"Huo","year":"2018","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0350","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0355","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1124\/dmd.116.070722","article-title":"Lansoprazole exacerbates pemetrexed-mediated hematologic toxicity by competitive inhibition of renal basolateral human organic anion transporter 3","volume":"44","author":"Ikemura","year":"2016","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0360","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1128\/MCB.01830-05","article-title":"Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2","volume":"26","author":"Itahana","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0365","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1078-0432.CCR-08-2081","article-title":"Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1","volume":"15","author":"Jandial","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0370","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1073\/pnas.1821809116","article-title":"Remote sensing and signaling in kidney proximal tubules stimulates gut microbiome-derived organic anion secretion","volume":"116","author":"Jansen","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.taap.2016.06.030","article-title":"P-gp, MRP2 and OAT1\/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate","volume":"306","author":"Jia","year":"2016","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0380","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1728","article-title":"The type I TGF-beta receptor is covalently modified and regulated by sumoylation","volume":"10","author":"Kang","year":"2008","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0385","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1124\/mol.107.039701","article-title":"Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1 alpha\/beta and DNA methylation","volume":"72","author":"Kikuchi","year":"2007","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0390","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.106.025494","article-title":"Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha\/beta and DNA methylation","volume":"70","author":"Kikuchi","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0395","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.yjmcc.2011.11.011","article-title":"Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction","volume":"52","author":"Kim","year":"2012","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0400","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0405","first-page":"5","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"e1000504","author":"Kolz","year":"2009","journal-title":"PLoS Genetics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0410","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0415","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0420","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jps.23433","article-title":"Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure","volume":"102","author":"Komazawa","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0425","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/dmd.116.074492","article-title":"Increased plasma exposures of conjugated metabolites of morinidazole in renal failure patients: A critical role of uremic toxins","volume":"45","author":"Kong","year":"2017","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0430","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/00498254.2014.1000430","article-title":"Evaluation of drug-drug interaction between the novel cPLA2 inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients","volume":"45","author":"Kozaki","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0435","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/ci4007134","article-title":"Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening","volume":"54","author":"Kumar","year":"2014","journal-title":"Journal of Chemical Information and Modeling"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0440","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.modgep.2005.07.007","article-title":"The expression patterns of deubiquitinating enzymes, USP22 and Usp22","volume":"6","author":"Lee","year":"2006","journal-title":"Gene Expression Patterns"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0445","doi-asserted-by":"crossref","first-page":"519","DOI":"10.21037\/atm.2016.11.81","article-title":"Cancer stem cells don\u2019t waste their time cleaning-low proteasome activity, a marker for cancer stem cell function","volume":"4","author":"Lenos","year":"2016","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0450","doi-asserted-by":"crossref","first-page":"21012","DOI":"10.1074\/jbc.M311972200","article-title":"The role of N-glycosylation in function and surface trafficking of the human dopamine transporter","volume":"279","author":"Li","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0455","doi-asserted-by":"crossref","first-page":"E378","DOI":"10.1152\/ajpendo.90713.2008","article-title":"Regulation of human organic anion transporter 1 by ANG II: involvement of protein kinase Calpha","volume":"296","author":"Li","year":"2009","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0460","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/mol.113.086769","article-title":"Three ubiquitination sites of organic anion transporter-1 synergistically mediate protein kinase C-dependent endocytosis of the transporter","volume":"84","author":"Li","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0465","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.jfda.2017.11.006","article-title":"Transporter-mediated interaction of indican and methotrexate in rats","volume":"26","author":"Lin","year":"2018","journal-title":"Journal of Food and Drug Analysis"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0470","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","article-title":"Regulation of uric acid excretion by the kidney","volume":"14","author":"Lipkowitz","year":"2012","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1951786","article-title":"Interaction of anticancer drugs with human organic anion transporter hOAT4","volume":"2019","author":"Liu","year":"2019","journal-title":"Journal of Oncology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.peptides.2012.04.003","article-title":"Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated rats","volume":"36","author":"Liu","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0485","first-page":"8","author":"Lozano","year":"2018","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0490","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","article-title":"Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans","volume":"59","author":"Maeda","year":"2014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0495","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bcp.2006.03.016","article-title":"Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha","volume":"72","author":"Maher","year":"2006","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0500","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1124\/mol.113.088229","article-title":"Hepatocyte nuclear factors 4alpha and 1alpha regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters","volume":"84","author":"Martovetsky","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0505","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.116.074294","article-title":"Quantitative prediction of human renal clearance and drug-drug interactions of organic anion transporter substrates using in vitro transport data: A relative activity factor approach","volume":"45","author":"Mathialagan","year":"2017","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040764","article-title":"Protein kinases C-mediated regulations of drug transporter activity, localization and expression","volume":"18","author":"Mayati","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0515","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1074\/jbc.M808507200","article-title":"Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK ativation","volume":"284","author":"Mines","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0520","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tcb.2010.01.007","article-title":"Sumoylation and other ubiquitin-like post-translational modifications in plants","volume":"20","author":"Miura","year":"2010","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0525","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.23567","article-title":"Precise comparison of protein localization among OCT, OAT, and MATE in human kidney","volume":"102","author":"Motohashi","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0530","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/emboj\/17.1.61","article-title":"Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus","volume":"17","author":"Muller","year":"1998","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0535","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2091","article-title":"Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3","volume":"38","author":"Narumi","year":"2017","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0540","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1124\/dmd.111.039115","article-title":"Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats","volume":"39","author":"Naud","year":"2011","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0545","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1478-811X-11-52","article-title":"When ubiquitination meets phosphorylation: a systems biology perspective of EGFR\/MAPK signalling","volume":"11","author":"Nguyen","year":"2013","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0550","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.RA119.010729","article-title":"Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning","volume":"295","author":"Nigam","year":"2020","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0555","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","article-title":"The SLC22 transporter family: A paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease","volume":"58","author":"Nigam","year":"2018","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0565","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/jpet.106.108233","article-title":"Human organic anion transporter 3 gene is regulated constitutively and inducibly via a cAMP-response element","volume":"319","author":"Ogasawara","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0570","doi-asserted-by":"crossref","first-page":"F1819","DOI":"10.1152\/ajprenal.00017.2007","article-title":"Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney","volume":"292","author":"Ogasawara","year":"2007","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0575","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/ATVBAHA.111.228478","article-title":"Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo","volume":"31","author":"Ogura","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0580","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","article-title":"An overview of drug-induced acute kidney injury","volume":"36","author":"Pannu","year":"2008","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0585","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1128\/AAC.01151-16","article-title":"Inhibitory interaction potential of 22 antituberculosis drugs on organic anion and cation transporters of the SLC22A family","volume":"60","author":"Parvez","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/srep16226","article-title":"Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure","volume":"5","author":"Peng","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165741","article-title":"Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation","volume":"1866","author":"Pengrattanachot","year":"2020","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0600","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MAJ.0b013e3182831740","article-title":"Decreased renal organic anion transporter 3 expression in type 1 diabetic rats","volume":"347","author":"Phatchawan","year":"2014","journal-title":"The American Journal of the Medical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","article-title":"Ubiquitin: Structures, functions, mechanisms","volume":"1695","author":"Pickart","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0610","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.1073\/pnas.1004712107","article-title":"One SUMO is sufficient to silence the dimeric potassium channel K2P1","volume":"107","author":"Plant","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000430328","article-title":"Regulation of expression of renal organic anion transporters OAT1 and OAT3 in a model of ischemia\/reperfusion injury","volume":"37","author":"Preising","year":"2015","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0620","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-3565(25)23220-7","article-title":"Rat renal cortical slices demonstrate p-aminohippurate\/glutarate exchange and sodium\/glutarate coupled p-aminohippurate transport","volume":"255","author":"Pritchard","year":"1990","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0625","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.neuron.2014.07.042","article-title":"Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death","volume":"83","author":"Qi","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0630","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molmet.2015.01.010","article-title":"Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic beta-cells via protein kinase A","volume":"4","author":"Rajan","year":"2015","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0635","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2005.01.019","article-title":"Sumoylation silences the plasma membrane leak K+ channel K2P1","volume":"121","author":"Rajan","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0640","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47798-x","article-title":"A network of SLC and ABC transporter and DME genes involved in remote sensing and signaling in the gut-liver-kidney axis","volume":"9","author":"Rosenthal","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0645","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0650","first-page":"1073","article-title":"Meclofenamate elicits a nephropreventing effect in a rat model of ischemic acute kidney injury by suppressing indoxyl sulfate production and restoring renal organic anion transporters","volume":"8","author":"Saigo","year":"2014","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0655","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/toxsci\/kfu119","article-title":"Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury","volume":"141","author":"Saito","year":"2014","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0660","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.107.128249","article-title":"Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha\/beta","volume":"324","author":"Saji","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0665","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2133\/dmpk.DMPK-13-NT-070","article-title":"A common variant of organic anion transporter 4 (OAT4\/SLC22A11) gene is associated with renal underexcretion type gout","volume":"29","author":"Sakiyama","year":"2014","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0670","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/B:PHAM.0000012153.71993.cb","article-title":"Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases","volume":"21","author":"Sakurai","year":"2004","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0675","doi-asserted-by":"crossref","first-page":"F198","DOI":"10.1152\/ajprenal.00160.2014","article-title":"Oat1\/3 restoration protects against renal damage after ischemic AKI","volume":"308","author":"Schneider","year":"2015","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0680","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.pharmtox.051208.165340","article-title":"Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology","volume":"49","author":"Schwartz","year":"2009","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0685","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.ackd.2016.01.016","article-title":"Drug transporter function--implications in CKD","volume":"23","author":"Schwenk","year":"2016","journal-title":"Advances in Chronic Kidney Disease"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0690","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.7314\/APJCP.2012.13.8.3583","article-title":"SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of beta-catenin","volume":"13","author":"Shen","year":"2012","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0695","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1093\/jxb\/ery295","article-title":"Orchestrating the proteome with post-translational modifications","volume":"69","author":"Spoel","year":"2018","journal-title":"Journal of Experimental Botany"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0700","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/00498250801927435","article-title":"Physiology, structure, and regulation of the cloned organic anion transporters","volume":"38","author":"Srimaroeng","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0705","article-title":"A novel SNP in the 5\u2019 regulatory region of organic anion transporter 1 is associated with chronic kidney disease","volume":"8","author":"Sun","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0710","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nucmedbio.2013.03.006","volume":"40","author":"Takahara","year":"2013","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0715","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.jrn.2006.04.020","article-title":"Accumulation of indoxyl sulfate in OAT1\/3-positive tubular cells in kidneys of patients with chronic renal failure","volume":"16","author":"Taki","year":"2006","journal-title":"Journal of Renal Nutrition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0720","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/mc.22687","article-title":"SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-betaRI","volume":"56","author":"Tan","year":"2017","journal-title":"Molecular Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0725","doi-asserted-by":"crossref","first-page":"14961","DOI":"10.1074\/jbc.M400197200","article-title":"Role of glycosylation in the organic anion transporter OAT1","volume":"279","author":"Tanaka","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0730","first-page":"528","article-title":"High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapy","volume":"4","author":"Tashiro","year":"2014","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0735","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bcp.2006.10.010","article-title":"Gene expression and regulation of drug transporters in the intestine and kidney","volume":"73","author":"Terada","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0740","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A Practical Review of Proteasome Pharmacology","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0745","first-page":"11","article-title":"Inhibitory effects of chemotherapeutics on human organic anion transporter hOAT4","volume":"7","author":"Toh","year":"2016","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0750","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tcb.2005.08.002","article-title":"Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest","volume":"15","author":"Ulrich","year":"2005","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0755","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.molcel.2008.10.010","article-title":"The fast-growing business of SUMO chains","volume":"32","author":"Ulrich","year":"2008","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0760","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2008020180","article-title":"Organic anion transporter 3 contributes to the regulation of blood pressure","volume":"19","author":"Vallon","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0765","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"VanWert","year":"2010","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0775","doi-asserted-by":"crossref","first-page":"p45","DOI":"10.1159\/000166996","article-title":"Time course of organic anion excretion in rats with bilateral ureteral obstruction: role of organic anion transporters (Oat1 and Oat3)","volume":"110","author":"Villar","year":"2008","journal-title":"Nephron. Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0780","doi-asserted-by":"crossref","first-page":"18853","DOI":"10.1074\/jbc.RA119.010785","article-title":"Importance of phosphorylation\/dephosphorylation cycles on lipid-dependent modulation of membrane protein topology by posttranslational phosphorylation","volume":"294","author":"Vitrac","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0785","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: A molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0790","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jphs.2017.12.011","article-title":"The activity of organic anion transporter-3: Role of dexamethasone","volume":"136","author":"Wang","year":"2018","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0795","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2015.11.024","article-title":"Serum- and glucocorticoid-inducible kinase SGK2 regulates human organic anion transporters 4 via ubiquitin ligase Nedd4-2","volume":"102","author":"Wang","year":"2016","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0800","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bdd.2085","article-title":"SGK1\/Nedd4-2 signaling pathway regulates the activity of human organic anion transporters 3","volume":"38","author":"Wang","year":"2017","journal-title":"Biopharmaceutics & Drug Disposition"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107647_bb0805","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbamem.2019.04.007","article-title":"The SUMO-specific protease Senp2 regulates SUMOylation, expression and function of human organic anion transporter 3","volume":"1861","author":"Wang","year":"2019","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0810","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1208\/s12248-019-0303-4","article-title":"Activation of protein kinase A stimulates SUMOylation, expression, and transport activity of organic anion transporter 3","volume":"21","author":"Wang","year":"2019","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0815","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2018.11.040","article-title":"The mechanistic links between insulin and human organic anion transporter 4","volume":"555","author":"Wang","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0820","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bcp.2013.08.016","article-title":"The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination","volume":"86","author":"Wang","year":"2013","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0825","article-title":"Interaction of natural dietary and herbal anionic compounds and flavonoids with human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)","volume":"2013","author":"Wang","year":"2013","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0830","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1208\/s12248-012-9413-y","article-title":"Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease","volume":"15","author":"Wang","year":"2013","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0835","doi-asserted-by":"crossref","first-page":"F1283","DOI":"10.1152\/ajprenal.00426.2014","article-title":"Transcriptional regulation of human organic anion transporter 1 by B-cell CLL\/lymphoma 6","volume":"307","author":"Wegner","year":"2014","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0840","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0845","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1097\/01.ASN.0000079040.55124.25","article-title":"Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalization","volume":"14","author":"Wolff","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0850","article-title":"Key role for the organic anion transporters, OAT1 and OAT3, in the in vivo handling of uremic toxins and solutes","volume":"7","author":"Wu","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0855","first-page":"881","article-title":"Ubiquitination regulation of inflammatory responses through NF-kappaB pathway","volume":"10","author":"Wu","year":"2018","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0860","article-title":"The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0865","first-page":"19","article-title":"Serum- and glucocorticoid-inducible kinase sgk2 stimulates the transport activity of human organic anion transporters 1 by enhancing the stability of the transporter","volume":"7","author":"Xu","year":"2016","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0870","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acs.molpharmaceut.5b00839","article-title":"An essential role of Nedd4-2 in the ubiquitination, expression, and function of organic anion transporter-3","volume":"13","author":"Xu","year":"2016","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0875","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/med.21397","article-title":"Posttranslational regulation of organic anion transporters by ubiquitination: Known and novel","volume":"36","author":"Xu","year":"2016","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0880","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00522.2015","article-title":"Nedd4-2 but not Nedd4-1 is critical for protein kinase C-regulated ubiquitination, expression, and transport activity of human organic anion transporter 1","volume":"310","author":"Xu","year":"2016","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0885","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2016.05.003","article-title":"Loops and layers of post-translational modifications of drug transporters","volume":"116","author":"Xu","year":"2017","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0890","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/dmd.117.075861","article-title":"PKC\/Nedd4-2 signaling pathway regulates the cell surface expression of drug transporter hOAT1","volume":"45","author":"Xu","year":"2017","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0895","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4161\/cc.2.6.597","article-title":"SUMO and transcriptional repression: Dynamic interactions between the MAP kinase and SUMO pathways","volume":"2","author":"Yang","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0900","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10157-013-0806-8","article-title":"Uric acid transporter ABCG2 is increased in the intestine of the 5\/6 nephrectomy rat model of chronic kidney disease","volume":"18","author":"Yano","year":"2014","journal-title":"Clinical and Experimental Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0905","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000356643","article-title":"Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: A propensity score matching study","volume":"86","author":"Yasui","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0910","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1002\/jps.23581","article-title":"Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8)","volume":"102","author":"Yee","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0915","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1074\/jbc.R800050200","article-title":"SUMOylation and De-SUMOylation: wrestling with life\u2019s processes","volume":"284","author":"Yeh","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0920","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/med.10019","article-title":"Structure, function, and regulation of renal organic anion transporters","volume":"22","author":"You","year":"2002","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0925","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1074\/jbc.275.14.10278","article-title":"Regulation of mOAT-mediated organic anion transport by okadaic acid and protein kinase C in LLC-PK(1) cells","volume":"275","author":"You","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0930","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.108.149476","article-title":"Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril","volume":"330","author":"Yuan","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0935","series-title":"Regulation of human organic anion transporter 1 through deubiquitinase (abstract)","author":"Zhang","year":"2017"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0940","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jphs.2018.01.006","article-title":"AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3","volume":"136","author":"Zhang","year":"2018","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0945","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.apsb.2019.05.005","article-title":"Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway","volume":"10","author":"Zhang","year":"2020","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0950","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb2522","article-title":"USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-beta type I receptor","volume":"14","author":"Zhang","year":"2012","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0955","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/mol.112.082065","article-title":"Lysine 48-linked polyubiquitination of organic anion transporter-1 is essential for its protein kinase C-regulated endocytosis","volume":"83","author":"Zhang","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0960","first-page":"242","article-title":"Short-term and long-term effects of protein kinase C on the trafficking and stability of human organic anion transporter 3","volume":"3","author":"Zhang","year":"2012","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0965","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00018-007-7137-4","article-title":"Sumoylation regulates diverse biological processes","volume":"64","author":"Zhao","year":"2007","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0970","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnagi.2016.00303","article-title":"Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases","volume":"8","author":"Zheng","year":"2016","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0975","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1128\/AAC.02414-14","article-title":"Effects of renal impairment on the pharmacokinetics of morinidazole: uptake transporter-mediated renal clearance of the conjugated metabolites","volume":"58","author":"Zhong","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0980","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/mol.104.007583","article-title":"The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4","volume":"67","author":"Zhou","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0985","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11095-006-9144-9","article-title":"Molecular insights into the structure-function relationship of organic anion transporters OATs","volume":"24","author":"Zhou","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0990","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1074\/jbc.M112.425272","article-title":"Ubiquitin-specific peptidase 8 (USP8) regulates endosomal trafficking of the epithelial Na+ channel","volume":"288","author":"Zhou","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107647_bb0995","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140569","article-title":"Evolutionary analysis and classification of OATs, OCTs, OCTNs, and other SLC22 transporters: Structure-function implications and analysis of sequence motifs","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:10:08Z","timestamp":1759011008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820301777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":199,"alternative-id":["S0163725820301777"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107647","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107647"}}